CA2985843A1 — Disposable pen needle with abbreviated non-patient end, and reusable pen interface
Assigned to Embecta Corp · Expires 2016-12-08 · 9y expired
What this patent protects
A medicament delivery system is disclosed including disposable pen needles (10, 60, 120) each having a stainless steel needle or cannula (12, 62, 122) with a concealed or a very short non-injection end (28, 78, 128) that is not intended to pierce the septum (8) of the drug storag…
USPTO Abstract
A medicament delivery system is disclosed including disposable pen needles (10, 60, 120) each having a stainless steel needle or cannula (12, 62, 122) with a concealed or a very short non-injection end (28, 78, 128) that is not intended to pierce the septum (8) of the drug storage compartment (6) of a medication pen (2), thus reducing the risk of needle stick injuries. Several types of non-metallic interfaces (30, 80, 100) serve as intermediaries between the pen needles ( 10, 60, 120) and a medication pen (2) and perform the septum-piercing function. These improve the flow of medicament to the needle or cannula (12, 62, 122) due to the larger lumen of the plastic interface (30, 80, 100) that directly feeds medicament to the needle or cannula (12, 62, 122), allowing for even smaller gauge needles for improved patient comfort.
Drugs covered by this patent
- Farxiga (DAPAGLIFLOZIN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.